The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Second pass at: Albumin binding and how it produces a long half-life

This is a generated summary. It shows the 5 most-liked posts from a topic of 12, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
B
BuchholzTL2Member22 Jun 2024#1

Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that.

A narrow question about Albumin binding, deliberately narrow, because the broad version has been asked here four times and produced four long threads and no answer.

One question, stated units, stated method, and what I have already ruled out.

22 likes 2.1y
RI
retention_indexTL2Analytical chemist1 Aug 2024#2

I had written a reply contradicting the opening post and deleted it. Here is what survived.

Counterpoint on Albumin binding, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.

25 likes 2y
AD
appeals_deskTL3Regular7 Nov 2024#6

That is consistent with mine, for whatever one more account is worth.

18 likes 21mo
LC
lu.cabreraTL226 Jan 2025 · edited#10
Buchholz, post #1: Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow question about Albumin binding, deliberately narrow, because the broad version has been asked here four times and produced four long threads and no answer. One question,… Go to post

Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding (different mechanism) which extends its half-life compared to an unmodified peptide.

12 likes in reply to #1 18mo
OL
o.lindgrenTL2Regular4 Mar 2025#12
appeals_desk, post #6: That is consistent with mine, for whatever one more account is worth. Go to post

Adding a data point of agreement rather than a data point.

28 likes in reply to #6 17mo

Read the full topic (12 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
SMVNICPAJH+58 64 9.7k 2mo
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. A narrow question about albumin binding, deliberately narrow, because the broad…
SDDMTBBTAM+38 44 6.6k 14mo
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
EDRFCHLIAK+110 126 14k 4mo
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about Washout, deliberately narrow, because the…
AWBWCEAWS+128 139 3k 3mo
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
MSPMAICLAP+104 110 16k 2d

Related topics — sharing the tags missed dose, worked example, semaglutide

TopicParticipantsRepliesViewsActivity
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did. Question about a metering device rather…
IDRSNG 2 18k 6h
Second pass at: Choosing a concentration on purpose rather than by accident
Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Choosing a…
SDNKEARSI+44 48 1k 19mo
Priming a pen and whether the primed volume is wasted
Priming a pen and whether the primed volume is wasted Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin priming a pen down and I want to…
ANGHCHFAFI+19 23 1.3k 2d
Restarting after a long gap: what the labelling implies — the long version
Restarting after a long gap: what the labelling implies — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
OFDIBRMHF+12 17 2.4k 2mo
Follow-up: Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
VSHKLMEKN 4 164 20mo